
Stephen Robert Broderick MD MPHS
Adult General Thoracic Surgery, Cardiovascular Surgery
Assistant Professor of Surgery, Johns Hopkins University School of Medicine
Join to View Full Profile
601 N Caroline StFl 8Baltimore, MD 21287
Phone+1 443-997-1508
Fax+1 443-769-1242
Dr. Broderick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Thoracic Surgery - Independent, 2010 - 2012
- New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 2003 - 2010
- Georgetown University School of MedicineClass of 2003
Certifications & Licensure
- DC State Medical License 2016 - 2026
- MD State Medical License 2016 - 2026
- MO State Medical License 2012 - 2016
- NY State Medical License 2006 - 2008
- American Board of Surgery Surgery
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Publications & Presentations
PubMed
- Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer.Mark M Awad, Patrick M Forde, Nicolas Girard, Jonathan Spicer, Changli Wang
Journal of Clinical Oncology. 2025-04-20 - The Society of Thoracic Surgeons 2024 Risk Models for Lung Cancer Resection: Continued Refinement and Improved Outcomes.Betty C Tong, Levi N Bonnell, Robert H Habib, David M Shahian, David Shersher
The Annals of Thoracic Surgery. 2025-04-01 - 1 citationsDivergent Clinical and Immunologic Outcomes Based on STK11 Co-mutation Status in Resectable KRAS-Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade.Samuel Rosner, Sydney Connor, Khaled Sanber, Marianna Zahurak, Tianbei Zhang
Clinical Cancer Research. 2025-01-17
Press Mentions
- VATS Robotic Assisted Bilobectomy and Complex Bronchoplastic Reconstruction and Closure for Synchronous Endobronchial Carcinoid TumorsMay 17th, 2022
- Immunotherapy plus Chemotherapy Before Surgery Improves Outcomes for Patients with Lung CancerApril 11th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: